Cell & Gene Therapy
The advent of cell and gene therapies has ushered in a bold new era of medicine, one where previously incurable diseases now have treatment options.
As you work to bring the promise of these innovative therapies into the clinic, MaxCyte® is here to accelerate your journey to success.
Designed with cell and gene therapy in mind
Over 20 years ago, MaxCyte’s technology was designed to overcome cell and gene therapy development barriers.
Today we partner with researchers who are actively assessing these therapies in clinical trials for treatment of genetic disease, hematologic malignancies, solid tumors and more. We are proud to be a part of many of the pioneering studies in this field.
How we enable cell and gene therapy development
Over the many years we’ve dedicated to optimizing and advancing electroporation, we’ve perfected an innovative technology that achieves key goals to streamline cell and gene therapy development:
- Highly efficient delivery of diverse payloads
- Nucleic acids
- Proteins
- Small molecules
- High cell viability after electroporation
- Seamless scalability with the same technology and general protocols from concept to clinic
- Simplified workflow with MaxCyte’s Electroporation Buffer
Research applications
Resources
Ready to learn how we can simplify your cell and gene therapy development?
Answers are just a click away!
